These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12227595)

  • 1. Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modelling.
    Khan SJ; Ongerth JE
    Water Sci Technol; 2002; 46(3):105-13. PubMed ID: 12227595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations.
    Khan SJ; Ongerth JE
    Chemosphere; 2004 Jan; 54(3):355-67. PubMed ID: 14575748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage.
    Carballa M; Omil F; Lema JM
    Chemosphere; 2008 Jul; 72(8):1118-23. PubMed ID: 18514761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the PhATE™ model.
    Cunningham VL; D'Aco VJ; Pfeiffer D; Anderson PD; Buzby ME; Hannah RE; Jahnke J; Parke NJ
    Integr Environ Assess Manag; 2012 Jul; 8(3):530-42. PubMed ID: 22162313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants.
    Okuda T; Yamashita N; Tanaka H; Matsukawa H; Tanabe K
    Environ Int; 2009 Jul; 35(5):815-20. PubMed ID: 19201472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge.
    Ternes TA; Herrmann N; Bonerz M; Knacker T; Siegrist H; Joss A
    Water Res; 2004 Nov; 38(19):4075-84. PubMed ID: 15491655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination.
    Zhang Y; Geissen SU
    Chemosphere; 2010 Sep; 80(11):1345-52. PubMed ID: 20594577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
    Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
    Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triclosan in a sewage treatment process--balances and monitoring data.
    Bester K
    Water Res; 2003 Sep; 37(16):3891-6. PubMed ID: 12909107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation.
    Jones-Lepp TL; Stevens R
    Anal Bioanal Chem; 2007 Feb; 387(4):1173-83. PubMed ID: 17131110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model for the flotation of waste activated sludge.
    Fujisaki K; El-Zahar M
    Water Sci Technol; 2002; 46(11-12):203-8. PubMed ID: 12523755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of bis(2-ethylhexyl) phthalate at a sewage treatment plant.
    Marttinen SK; Kettunen RH; Sormunen KM; Rintala JA
    Water Res; 2003 Mar; 37(6):1385-93. PubMed ID: 12598201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment.
    Nakada N; Tanishima T; Shinohara H; Kiri K; Takada H
    Water Res; 2006 Oct; 40(17):3297-303. PubMed ID: 16938339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of enhanced CSO treatment in secondary clarifiers with a modified Activated Sludge Model no. 3.
    Ahnert M; Günther N; Kuehn V; Krebs P; Svardal K; Spatzierer G
    Water Sci Technol; 2008; 58(3):609-15. PubMed ID: 18725729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-based modelling and proportional-integral-plus (pip) control of nitrate in an activated sludge benchmark.
    Ghavipanjeh F; Taylor CJ; Young PC; Chotai A
    Water Sci Technol; 2001; 44(1):87-94. PubMed ID: 11496682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
    Carballa M; Omil F; Lema JM; Llompart M; García-Jares C; Rodríguez I; Gómez M; Ternes T
    Water Res; 2004 Jul; 38(12):2918-26. PubMed ID: 15223286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
    Christensen AM; Markussen B; Baun A; Halling-Sørensen B
    Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge.
    Carballa M; Omil F; Ternes T; Lema JM
    Water Res; 2007 May; 41(10):2139-50. PubMed ID: 17399761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.